Results 11 to 20 of about 249,854 (357)

Antiplatelet resistance in stroke [PDF]

Expert Review of Neurotherapeutics, 2011
Although the exact prevalence of antiplatelet resistance in ischemic stroke is not known, estimates about the two most widely used antiplatelet agents - aspirin and clopidogrel - suggest that the resistance rate is high, irrespective of the definition used and parameters measured. Inadequate antiplatelet responsiveness correlates with an increased risk
Mehmet Akif Topcuoglu, Ethem Murat Murat Arsava   +1 more
exaly   +3 more sources

Sorghum Protein Extract Protects RBC from Sodium Nitrite-Induced Oxidative Stress and Exhibits Anticoagulant and Antiplatelet Activity [PDF]

Folia Medica, 2021
Introduction: Oxidative stress plays a critical role in the progression of diabetes, arthritis, cancer, eryptosis, cardiovascular disease, and thrombosis. Currently, antioxidants from natural sources are in high demand due to their beneficial role in the
Devaraja Sannaningaiah, Ashwini Shivaiah, Jayanna Kengaiah, Chandramma Srinivasa, Sharath Kumar M. Nandish, Chethana Ramachandraiah, Sujatha Hanumegowda, Bhagyalakshmi Manjappa, Sebastin Santosh Martin, Ramesh Komalapura Laxmaiah, Manohar Shinde   +10 more
doaj   +3 more sources

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Российский кардиологический журнал, 2021
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment ...
J.-P. Collet, H. Thiele, E. Barbato, O. Barthélémy, J. Bauersachs, D. L. Bhatt, P. Dendale, M. Dorobantu, T. Edvardsen, T. Folliguet, Ch. P. Gale, M. Gilard, A. Jobs, P. Jüni, E. Lambrinou, B. S. Lewis, Ju. Mehilli, E. Meliga, B. Merkely, O. Mueller, M. Roffi, F. H. Rutten, D. Sibbing, G. C.M. Siontis   +23 more
doaj   +1 more source

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

European Journal of Cardio-Thoracic Surgery, 2018
The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC)and of the European Association for Cardio-Thoracic Surgery(EACTS)
M. Valgimigli, H. Bueno, R. Byrne, J. Collet, F. Costa, A. Jeppsson, P. Jüni, A. Kastrati, P. Kolh, L. Mauri, G. Montalescot, F. Neumann, M. Petricevic, M. Roffi, P. Steg, S. Windecker, J. Zamorano, G. Levine   +17 more
semanticscholar   +3 more sources

Antithrombotic therapy after transcatheter aortic valve replacement

Heart Views, 2022
Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk.
Tariq A.M. Mousa, Ahmed Mahfouz, Nazar Mohammed   +2 more
doaj   +1 more source

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

New England Journal of Medicine, 2021
BACKGROUND The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear.
M. Valgimigli, E. Frigoli, D. Heg, J. Tijssen, P. Jüni, P. Vranckx, Y. Ozaki, M. Morice, B. Chevalier, Y. Onuma, S. Windecker, P. Tonino, M. Roffi, M. Lesiak, F. Mahfoud, J. Bartunek, D. Hildick-Smith, A. Colombo, G. Stanković, A. Íñiguez, C. Schultz, R. Kornowski, P. Ong, M. Alasnag, Alfredo E. Rodríguez, Aris Moschovitis, P. Laanmets, M. Donahue, S. Leonardi, P. Smits   +29 more
semanticscholar   +1 more source

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial

Frontiers in Cardiovascular Medicine, 2021
Aims: In this pre-specified analysis of the “endothelium, stent and antiplatelet therapy” study, we investigate the impact of antiplatelet therapies on microvascular function in patients undergoing stenting for an acute coronary syndrome.Methods and ...
Boris Schnorbus, Boris Schnorbus, Kerstin Jurk, Karl J. Lackner, Caroline Welk, Thomas Münzel, Tommaso Gori, Tommaso Gori   +7 more
doaj   +1 more source

The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors

Frontiers in Immunology, 2022
Patients with COVID-19 often have hypoxemia, impaired lung function, and abnormal imaging manifestations in acute and convalescent stages. Alveolar inflammation, pulmonary vasculitis, and thromboembolism synergistically damage the blood-air barrier ...
Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Langjiao Liu, Chunxu Wang, Yufeng Wang, Valerie A. Novakovic, Jialan Shi, Jialan Shi, Jialan Shi   +9 more
doaj   +1 more source

Bridging therapy according to new clinical guidelines: A review

Consilium Medicum, 2022
In modern world it is really important to know how to manage patients taking anticoagulant or antiplatelet therapy. There is an increasing number of patients, who have gone through PCI or any other cardiac intervention and who also need another surgery ...
Tatiana A. Pavlenko, Anastasiya Yu. Lebedeva, Denis N. Protsenko   +2 more
doaj   +1 more source

Antiplatelet drugs [PDF]

British Journal of Pharmacology, 2006
British Journal of Pharmacology (2006) 147, S241–S251.
Gustav, Born, Carlo, Patrono
openaire   +2 more sources